查詢結果分析
來源資料
相關文獻
- 鈣離子阻斷劑對普樂可復誘導牙齦腫大之影響
- 藥物引起牙齦腫大之探討及治療
- 環孢靈對口腔組織之影響:文獻回顧
- Cyclosporine is a Safe and Effective Immunosuppressant in Treating Steroid-dependent or-Resistant Nephrotic Patients
- 環孢靈誘發之牙齦腫大
- 免疫抑制劑--環孢靈素A和FK506
- 舊瓶裝新酒--談環孢靈於C型肝炎治療之角色
- 以Tacrolimus治療原發性腎絲球腎炎
- Experience of Using FK 506 as a Rescue Therapy for Refractory Hepatic Allograft Rejection
- 血管收縮素轉化酶抑制劑在糖尿病病人的使用
頁籤選單縮合
題 名 | 鈣離子阻斷劑對普樂可復誘導牙齦腫大之影響=Effect of Calcium Channel Blockers on Tacrolimus-induced Gingival Overgro |
---|---|
作 者 | 陳聖怡; 葉育文; 鄭琬蒨; 邱賢忠; 傳鍔; 江正陽; | 書刊名 | 臺灣牙周病醫學會雜誌 |
卷 期 | 14:2 2009.06[民98.06] |
頁 次 | 頁125-137 |
分類號 | 416.946 |
關鍵詞 | CCB; 牙齦腫大; 普樂可復; 環孢靈; 免疫抑制劑; 抗癲癇藥物; 抗痙癴藥物; 鈣離子阻斷劑; Gingival overgrowth; FK506; Tacrolimus; Cyclosporin A; Immunosuppressants; Antiepileptic drugs; Anticonvulsants; Calcium channel blocker; |
語 文 | 中文(Chinese) |
中文摘要 | 普樂可複(Tacrolimus/FK506)爲1984年發展的新免疫抑制劑,其藥理機轉與環孢(Cyclosporin A)相似。由於服用環抱靈患者有牙齦腫大之副作用,因此普樂可複是否也引發該副作用,已廣被探討,卻差異甚遠、意見分歧。因此本文就普樂可複之藥物發展史、免疫抑制之機轉、誘導牙齦腫大之可能性、共同使用藥物對腫大之影響、及與環孢造成牙齦腫大的比較等做一整體之探討,尤其是有關普樂可複是否會造成牙齦腫大及鈣離子阻斷劑對該腫大之影響二項,更宜謹慎分析,以作爲未來臨床治療及研究之參考。 |
英文摘要 | Tacrolimus was introduced in 1984 as a new immunosuppressive agent. The pharmacodynamics of tacrolimus are very similar to those of cyclosporine-A. Some patients who use cyclosporine-A have the side effect of gingival overgrowth. Whether tacrolimus can induce gingival overgrowth has been widely discussed, but the conclusion is still controversial. The purpose of this article was discussed about the pharmacy in the development of tacrolimus, the immuno-suppressant mechanisms of the drug, the possibility of inducing gingival overgrowth, the effect of concomitant drug on the overgrowth, and the comparison of the induced gingival overgrowth to that induced by cyclosporine-A. Whether tacrolimus with or without concomitant use of calcium channel blockers can induce gingival overgrowth, the issue will become very important for clinical therapies and future researches. |
本系統中英文摘要資訊取自各篇刊載內容。